What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Immunology, Internal medicine, Minimal residual disease, Acute lymphocytic leukemia and Leukemia are his primary areas of study.
The Immunology study combines topics in areas such as Interleukin 12 and Cancer research.
His study in Internal medicine is interdisciplinary in nature, drawing from both Immunophenotyping, Oncology and Pediatrics.
Dario Campana combines subjects such as Neoplasm, Flow cytometry and Cumulative incidence with his study of Minimal residual disease.
Dario Campana has included themes like Chemotherapy, Gastroenterology, Childhood Acute Lymphoblastic Leukemia, Philadelphia chromosome and Bone marrow in his Acute lymphocytic leukemia study.
His studies in Leukemia integrate themes in fields like Molecular biology, Haematopoiesis and Myeloid leukemia.
His most cited work include:
- Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. (1743 citations)
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (1109 citations)
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (1109 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Minimal residual disease, Internal medicine, Leukemia and Cancer research.
As part of the same scientific family, Dario Campana usually focuses on Immunology, concentrating on Interleukin 12 and intersecting with Natural killer cell.
His Minimal residual disease research is multidisciplinary, relying on both Childhood Acute Lymphoblastic Leukemia, Myeloid leukemia, Flow cytometry and Polymerase chain reaction.
His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His work deals with themes such as Myeloid, Hematology, Hematopoietic stem cell transplantation and Haematopoiesis, which intersect with Leukemia.
His work carried out in the field of Cancer research brings together such families of science as Cell, Cell therapy, Receptor, Cytotoxicity and Immunotherapy.
He most often published in these fields:
- Immunology (50.41%)
- Minimal residual disease (49.59%)
- Internal medicine (42.78%)
What were the highlights of his more recent work (between 2013-2021)?
- Minimal residual disease (49.59%)
- Cancer research (29.43%)
- Internal medicine (42.78%)
In recent papers he was focusing on the following fields of study:
Dario Campana mainly investigates Minimal residual disease, Cancer research, Internal medicine, Oncology and Immunology.
Dario Campana interconnects Body mass index, Clinical trial, Pediatrics and Clinical significance in the investigation of issues within Minimal residual disease.
The Cancer research study combines topics in areas such as Cancer, Immunotherapy, Cell, T cell and Antibody-dependent cell-mediated cytotoxicity.
Internal medicine is closely attributed to Gastroenterology in his work.
His research in Oncology intersects with topics in Down syndrome, Hematopoietic stem cell transplantation, Myeloid leukemia and Lymphoblastic Leukemia.
Dario Campana focuses mostly in the field of Immunology, narrowing it down to matters related to NKG2D and, in some cases, Interleukin 12, Natural killer cell and CD3.
Between 2013 and 2021, his most popular works were:
- Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease (161 citations)
- T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killing. (138 citations)
- NK cells for cancer immunotherapy. (119 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Dario Campana mostly deals with Minimal residual disease, Immunology, Pediatrics, Immunotherapy and Cancer research.
His Minimal residual disease study necessitates a more in-depth grasp of Internal medicine.
His study ties his expertise on Interleukin 12 together with the subject of Immunology.
The various areas that Dario Campana examines in his Pediatrics study include Childhood Acute Lymphoblastic Leukemia, Clinical trial and Remission induction.
His Immunotherapy research integrates issues from Receptor and Antigen.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell, Antibody and T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
